Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tojo

Showing results (61-70 of 3,144) with videos related to

Pageof 315
Sort By:
Chemical & Pharmaceutical Bulletin|November 2, 2004
A pharmacokinetic model for ocular drug deliveryKakuji Tojo
Ryumachi. [Rheumatism]|January 1, 1977
[Etiology of malignant rheumatoid arthritis. (3-2) Etiology of malignant rheumatoid arthritis and antinuclear antibodies]T Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 15, 2000
[Anti-DNA (dsDNA, ssDNA) antibodies]T Tojo
No to Hattatsu = Brain and Development|May 1, 1996
[Therapeutic effect of "Ueda" method for a case of spastic paraplegia as a sequela of transverse myelitis]M Tojo
Japanese Journal of Medicine|November 1, 1990
Marker antibodies in systemic autoimmune diseasesT Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1990
[Clinical significance of antiadrenocortical antibody assay]T Tojo
International Journal of Nephrology|November 30, 2019
Mechanism Underlying Selective Albuminuria in Minimal Change Nephrotic SyndromeAkihiro Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1977
[Alport's syndrome]S Tojo
Journal of Anesthesia|January 17, 2026
Beyond routine: evidence and uncertainty in intraoperative oxygen titrationKentaro Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Kinase inhibitors against hematological malignancies]Arinobu Tojo
Pageof 315

Showing results (61-70 of 3,144) with videos related to

Sort By:
Pageof 315
Chemical & Pharmaceutical Bulletin|November 2, 2004
A pharmacokinetic model for ocular drug deliveryKakuji Tojo
Ryumachi. [Rheumatism]|January 1, 1977
[Etiology of malignant rheumatoid arthritis. (3-2) Etiology of malignant rheumatoid arthritis and antinuclear antibodies]T Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 15, 2000
[Anti-DNA (dsDNA, ssDNA) antibodies]T Tojo
No to Hattatsu = Brain and Development|May 1, 1996
[Therapeutic effect of "Ueda" method for a case of spastic paraplegia as a sequela of transverse myelitis]M Tojo
Japanese Journal of Medicine|November 1, 1990
Marker antibodies in systemic autoimmune diseasesT Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1990
[Clinical significance of antiadrenocortical antibody assay]T Tojo
International Journal of Nephrology|November 30, 2019
Mechanism Underlying Selective Albuminuria in Minimal Change Nephrotic SyndromeAkihiro Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1977
[Alport's syndrome]S Tojo
Journal of Anesthesia|January 17, 2026
Beyond routine: evidence and uncertainty in intraoperative oxygen titrationKentaro Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Kinase inhibitors against hematological malignancies]Arinobu Tojo
Pageof 315